Digital Health Solutions for Chronic Conditions Market Report 2025

The digital health solutions for chronic conditions market size has grown rapidly in recent years. It will grow from $229.24 billion in 2024 to $270.14 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. Growth in the historic period was driven by the rising prevalence of diabetes and cardiovascular disorders, increasing government support for e-health adoption, growing awareness of digital self-management tools, higher use of smartphones for health tracking, and greater demand for home-based care solutions.

The digital health solutions for chronic conditions market size is expected to see rapid growth in the next few years. It will grow to $514.55 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. Growth in the forecast period is expected to result from a stronger focus on precision and personalized medicine, increasing adoption of 5G for real-time monitoring, greater emphasis on preventive healthcare models, rising need for integrated chronic care platforms, and an expanding shift toward patient-centric digital ecosystems. Primary trends anticipated for the forecast period include advancements in personalized digital therapeutics, enhanced blockchain-enabled health data security, development of interoperable platforms for chronic disease management, innovations in continuous glucose and cardiac monitoring, and progress in gamified patient engagement solutions.

The increasing prevalence of diabetes is expected to drive the growth of the digital health solutions for chronic conditions market. Diabetes is a chronic metabolic disorder where the body either doesn't produce enough insulin or cannot effectively use the insulin it produces. The rise in diabetes is largely due to sedentary lifestyles, which contribute to obesity and insulin resistance. Digital health solutions support diabetes management by offering real-time blood glucose monitoring, allowing patients to continuously track their levels and adjust their diet, medication, or lifestyle for better blood sugar control. According to the International Diabetes Federation (IDF) in April 2.02 trillion people had diabetes in 2024, and the number is projected to rise to 853 million by 2050. This growing prevalence is driving demand for digital health solutions for chronic conditions.

Companies in the digital health solutions market are focusing on advanced technologies such as real-time injection monitoring to improve treatment accuracy, patient adherence, and overall management of chronic diseases. Real-time injection monitoring refers to digital systems that track medication administration in real time, providing both patients and healthcare providers with timely data to optimize dosing, ensure compliance, and reduce the risk of complications. For example, in April 2025, Ypsomed Holding AG, a Swiss-based developer of injection and infusion systems, and Sidekick Health, an Iceland-based digital therapeutics provider, launched a collaborative solution for obesity management. This solution combines Ypsomed’s connected devices with Sidekick’s digital therapeutics platform to offer personalized care, featuring continuous monitoring, behavior change support, and lifestyle coaching. The collaboration aims to enhance treatment adherence and improve long-term health outcomes by integrating connected medical technology with digital therapeutics, offering comprehensive support throughout the obesity management journey.

In July 2025, Samsung Electronics Co. Ltd., a South Korea-based electronics giant, acquired Xealth, a U.S.-based company specializing in digital health solutions for chronic conditions. Through this acquisition, Samsung aims to integrate digital health capabilities into its broader ecosystem, enabling more personalized care management and improving patient engagement.

Major players in the digital health solutions for chronic conditions market are ResMed Inc., Teladoc Health Inc., Noom Inc., Personify Health Inc., Biofourmis Inc., Vida Health Inc., Virta Health Inc., Omada Health Inc., Mahalo Health Inc., DarioHealth Corp., Sidekick Health Inc., WellDoc Inc., Lark Health Inc., Voluntis Inc., One Drop Inc., Kaia Health Software GmbH, CureApp Inc., Riva Health Inc., Sweetch-Health Ltd., and Canary Health Inc.

North America was the largest region in the digital health solutions for chronic conditions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital health solutions for chronic conditions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the digital health solutions for chronic conditions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Digital health solutions for chronic conditions are technology-driven tools designed to monitor, manage, and support patients living with long-term illnesses. They use digital platforms, mobile applications, and connected devices to track health metrics, provide personalized care guidance, and facilitate communication between patients and healthcare providers. These solutions aim to improve treatment adherence, enhance quality of life, and reduce the risk of complications associated with chronic diseases.

The primary types of digital health solutions for chronic conditions include diabetes, cardiovascular diseases, chronic respiratory diseases, and others. Diabetes is a chronic medical condition in which the body cannot properly produce or use insulin, leading to elevated blood sugar levels. Applications include both enterprise and personal use, and primary end users include payers and employers, hospitals and clinics, pharmaceutical and life sciences companies, homecare providers, and patients and caregivers.

The digital health solutions for chronic conditions market research report is one of a series of new reports that provides digital health solutions for chronic conditions market statistics, including the digital health solutions for chronic conditions industry global market size, regional shares, competitors with the digital health solutions for chronic conditions market share, detailed digital health solutions for chronic conditions market segments, market trends, and opportunities, and any further data you may need to thrive in the digital health solutions for chronic conditions industry. This digital health solutions for chronic conditions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital health solutions for chronic conditions market consists of revenues earned by entities by providing services such as remote patient monitoring, teleconsultation, disease management programs, medication adherence support, and health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital health solutions for chronic conditions market also includes sales of wearable health trackers, glucose monitors, blood pressure monitors, smart inhalers, pulse oximeters, connected scales, continuous glucose monitoring devices, smart medication dispensers, and fitness bands. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.